Page last updated: 2024-10-16

aminolevulinic acid and Complications, Pregnancy

aminolevulinic acid has been researched along with Complications, Pregnancy in 7 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soergel, P1
Makowski, L1
Makowski, E1
Schippert, C1
Hertel, H1
Hillemanns, P1
JAMES, GW1
RUDOLPH, SG1
ABBOTT, LD1
Altmann, P1
Maruna, RF1
Maruna, H1
Michalica, W1
Wagner, G1
Zegarski, W1
Dubicki, J1
Krasnowiecki, A1
Singh, NP1
Thind, IS1
Vitale, LF1
Pawlow, M1
Isenschmid, M1
König, C1
Fässli, C1
Haenel, A1
Hänggi, W1
Schneider, H1
Gorchein, A1
Webber, R1

Other Studies

7 other studies available for aminolevulinic acid and Complications, Pregnancy

ArticleYear
Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity.
    Lasers in surgery and medicine, 2011, Volume: 43, Issue:7

    Topics: Aminolevulinic Acid; Cervix Uteri; Conization; Cost-Benefit Analysis; Female; Germany; Health Care C

2011
Delta-amino-levulinic acid, porphobilinogen, and porphyrin excretion throughout pregnancy in a patient with acute intermittent porphyria with "passive porphyria" in the infant.
    The Journal of laboratory and clinical medicine, 1961, Volume: 58

    Topics: Amino Acids; Aminolevulinic Acid; Female; Humans; Infant, Newborn, Diseases; Porphobilinogen; Porphy

1961
[Lead detoxication effect of a combined calcium phosphate and ascorbic acid therapy in pregnant women with increased lead burden (author's transl)].
    Wiener medizinische Wochenschrift (1946), 1981, Volume: 131, Issue:12

    Topics: Aminolevulinic Acid; Ascorbic Acid; Cadmium; Cadmium Poisoning; Calcium Phosphates; Female; Humans;

1981
[Evaluation of lead intoxication exposure of the workers of porcelain producing plant "Lubiana" (author's transl)].
    Przeglad lekarski, 1981, Volume: 38, Issue:8

    Topics: Adult; Aminolevulinic Acid; Ceramics; Erythrocyte Count; Erythrocytes; Female; Humans; Lead; Lead Po

1981
Lead content of tissues of baby rats born of, and nourished by lead-poisoned mothers.
    The Journal of laboratory and clinical medicine, 1976, Volume: 87, Issue:2

    Topics: Aminolevulinic Acid; Animals; Animals, Newborn; Body Weight; Brain; Breast Feeding; Erythrocytes; Fe

1976
[Acute intermittent porphyria in pregnancy: glucose or hematin therapy?].
    Schweizerische medizinische Wochenschrift, 1992, Nov-14, Volume: 122, Issue:46

    Topics: Acute Disease; Adult; Aminolevulinic Acid; Drug Therapy, Combination; Female; Glucose Solution, Hype

1992
delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects.
    Clinical science (London, England : 1979), 1987, Volume: 72, Issue:1

    Topics: Adult; Aminolevulinic Acid; Erythrocytes; Female; Hemin; Humans; Kidney Failure, Chronic; Levulinic

1987